A Study of STI-3031 (an Anti-PD-L1 Antibody) in Patients With Selected Relapsed/Refractory Malignancies
Sorrento Therapeutics, Inc.
Sorrento Therapeutics, Inc.
National Institutes of Health Clinical Center (CC)
National Cancer Centre, Singapore
University of California, San Diego
University of Texas Southwestern Medical Center
University of Miami
Fred Hutchinson Cancer Center
Children's Oncology Group
Barbara Ann Karmanos Cancer Institute
Enzon Pharmaceuticals, Inc.